Cannabist Company Holdings (CBSTQ) AI Stock Analysis
Cannabist Company Holdings
(Other OTC:CBSTQ)
No summary available
Cannabist Company Holdings (CBSTQ) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $14.48M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.1
- Beta (1Y)
- 83.32
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 1,681
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Cannabist Company Holdings Business Overview & Revenue Model
Company Description
The Cannabist Company Holdings, Inc. engages in the production and sale of cannabis-based medicinal products. Its brands include Classix, Triple Seven, Seed and Stain, Amber, PRESS, and Hedy. The company was founded by Nicholas Keane Vita and Michael...
Cannabist Company Holdings Earnings Call Summary
The earnings call reflected a mixed performance with significant operational improvements and strategic market exits, but also faced challenges with revenue decline and margin pressures. The company is focusing on liquidity management and operational simplification to address these issues.
Q2-2025 Updates
Positive Updates
Negative Updates
Company Guidance
During The Cannabist Company's second quarter 2025 earnings call, several key metrics and strategic initiatives were highlighted. The company reported $87 million in revenue, a slight 1% decrease from the previous quarter, primarily due to asset sales and pricing pressures. They achieved an adjusted EBITDA of $8.5 million, with a 30 basis point improvement in margin to 9.8%. Wholesale revenue increased by 16% sequentially, contributing to 21% of total revenue, despite a decline in wholesale gross margin due to inventory reduction efforts. The company is actively managing liquidity, reducing costs, and restructuring operations, including divesting assets in Florida, California, Illinois, and Pennsylvania. They closed the quarter with $15.5 million in cash and plan to enhance revenue streams through new agreements in Pennsylvania. Additionally, the company aims to maintain CapEx below $3 million per quarter, focusing on new store openings and operational enhancements.
Cannabist Company Holdings Risk Analysis
Cannabist Company Holdings disclosed 78 risk factors in its most recent earnings report. Cannabist Company Holdings reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
1 New RiskCannabist Company Holdings Peers Comparison
Overall Rating
TSE:XLY83Outperform
TSE:LOVE77Outperform
TSE:GRIN47Neutral
TSE:JUSH42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TSE:XLY | 83Outperform | CAD 373.71M | 10.87 | 18.12% | ― | 18.79% | 10.74% |
| TSE:LOVE | 77Outperform | CAD 198.55M | 17.69 | 9.45% | ― | 14.66% | -33.72% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:GRIN | 47Neutral | CAD 114.97M | -21.71 | -12.66% | ― | 34.29% | -307.69% |
| TSE:JUSH | 42Neutral | CAD 133.80M | -1.72 | 40.27% | ― | 5.37% | 17.78% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CBSTQ | Cannabist Company Holdings Inc | 0.03 | -0.04 | -57.14% | |
| TSE:JUSH | Jushi Holdings Inc | 0.67 | -0.20 | -22.99% | |
| TSE:XLY | Auxly Cannabis Group (Otc) | 3.62 | 1.45 | 66.82% | |
| TSE:GRIN | Grown Rogue International | 0.46 | -0.05 | -9.80% | |
| TSE:LOVE | Cannara Biotech, Inc. | 2.01 | 0.32 | 18.93% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.